Connect with us on LinkedIn - Oblique

Search
News
Press releases
Partnering
Contact
Work with us

Vision
- Idea and vision
About us
- Our team
R&D
- Tech platform: Abiprot® antibody platform
- Scientific publications
Portfolio
- Pipeline
- Programs
Corporate Governance
Investor Relations

Connect with us on LinkedIn

Connect with us on LinKedin

https://www.linkedin.com/company/oblique-therapeutics-ab

Contact

Oblique Therapeutics AB (publ)info@obliquet.com

Gothenburg

413 46 Göteborg

Arvid Wallgrens Backe 20

Sweden

Stockholm

113 52 Stockholm

Döbelnsgatan 64

Sweden

Menu

Vision
About us
R&D
Portfolio
Corporate Governance
Investor Relations
Privacy Policy
Disclaimer

About

Oblique Therapeutics AB (publ) is a Swedish biotech company developing innovative new medicines for severe diseases with a large unmet medical need focusing on pain, and advanced cancer. The company uses Abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome.

Follow us on LinkedIn

Copyright © 2021 Oblique Therapeutics AB (publ)